Increasing use of antidepressants in pregnancy

American Journal of Obstetrics and Gynecology

Volumn 196, Issue 6, 2007, Pages 544.e1-544.e5

  Cooper, William O ^a   Willy, Mary E ^b   Pont, Stephen J ^a   Ray, Wayne A ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Center for Drug Evaluation and Research   (United States)

Author keywords

antidepressants; fetal effects; medication exposures; pregnancy

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; AMOXAPINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DOXEPIN; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MAPROTILINE; MIRTAZAPINE; NORTRIPTYLINE; PAROXETINE; PHENELZINE; PROTRIPTYLINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TETRACYCLIC ANTIDEPRESSANT AGENT; TRANYLCYPROMINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE; VENLAFAXINE;

ADULT; ANALYTIC METHOD; ARTICLE; BIRTH CERTIFICATE; COHORT ANALYSIS; EDUCATION; EUROPEAN AMERICAN; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; MEDICAL RECORD; PREGNANCY; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 34249752695     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2007.01.033     Document Type: Article

References (28)

1. Pirraglia P.A., Stafford R.S., and Singer D.E. Trends in prescribing of selective serotonin reuptake inhibitors and other newer antidepressant agents in adult primary care. Prim Care Companion. J Clin Psychiatry 5 (2003) 153-157
2. Kallen B. Fluoxetine use in early pregnancy. Birth Defects Res B Dev Reprod Toxicol 71 (2004) 395-396
3. Chambers C.D., Johnson K.A., Dick L.M., Felix R.J., and Jones K.L. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 335 (1996) 1010-1015
4. Moses-Kolko E.L., Bogen D., Perel J., et al. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA 293 (2005) 2372-2383
5. Food and Drug Administration. FDA Public health advisory: paroxetine. Electronic citation. Available at: http://www.fda.gov/cder/drug/advisory/paroxetine200512.htm. Accessed March 2, 2007.
6. Chambers C.D., Hernandez-Diaz S., Van Marter L.J., et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 354 (2006) 579-587
7. Bennett H.A., Einarson A., Taddio A., Koren G., and Einarson T.R. Prevalence of depression during pregnancy: systematic review. Obstet Gynecol 103 (2004) 698-709
8. Mills J.L. Depressing observations on the use of selective serotonin-reuptake inhibitors during pregnancy. N Engl J Med 354 (2006) 636-638
9. Ray W.A., and Griffin M.R. Use of Medicaid data for pharmacoepidemiology. Am J Epidemiol 129 (1989) 837-849
10. West S.L., Savitz D.A., Koch G., Strom B.L., Guess H.A., and Hartzema A. Recall accuracy for prescription medications: self-report compared with database information. Am J Epidemiol 142 (1995) 1103-1112
11. Johnson R.E., and Vollmer W.M. Comparing sources of drug data about the elderly. J Am Geriatr Soc 39 (1991) 1079-1084
12. Piper J.M., Mitchel Jr. E.F., Snowden M., Hall C., Adams M., and Taylor P. Validation of 1989 Tennessee birth certificates using maternal and newborn hospital records. Am J Epidemiol 137 (1993) 758-768
13. Cooper W.O., Ray W.A., and Griffin M.R. Prenatal prescription of macrolide antibiotics and infantile hypertrophic pyloric stenosis. Obstet Gynecol 100 (2002) 101-106
14. Cooper W.O., Hernandez-Diaz S., Arbogast P.G., et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 354 (2006) 2443-2451
15. Piper J.M., Ray W.A., Griffin M.R., Fought R., Daughtery J.R., and Mitchel Jr. E. Methodological issues in evaluating expanded Medicaid coverage for pregnant women. Am J Epidemiol 132 (1990) 561-571
16. Dupont W. Statistical modeling for biomedical researchers: a simple introduction to the analysis of complex data (2002), Cambridge University Press, Cambridge, UK
17. Sleath B.L., Jackson E., Thomas K.C., et al. Racial differences in the use of antidepressants and counseling for depression among homeless women. Community Ment Health J 42 (2006) 77-85
18. Rich-Edwards J.W., Kleinman K., Abrams A., et al. Sociodemographic predictors of antenatal and postpartum depressive symptoms among women in a medical group practice. J Epidemiol Community Health 60 (2006) 221-227
19. Malm H., Klaukka T., and Neuvonen P.J. Risks associated with selective serotonin reuptake inhibitors in pregnancy. Obstet Gynecol 106 (2005) 1289-1296
20. Andrade S.E., Raebel M.A., Morse A.N., et al. Use of prescription medications with a potential for fetal harm among pregnant women. Pharmacoepidemiol Drug Saf 15 (2006) 546-554
21. Reefhuis J., Rasmussen S.A., and Friedman J.M. Selective serotonin-reuptake inhibitors and persistent pulmonary hypertension of the newborn. N Engl J Med 354 (2006) 2188-2190
22. Thomas M.R., Waxmonsky J.A., Gabow P.A., Flanders-McGinnis G., Socherman R., and Rost K. Prevalence of psychiatric disorders and costs of care among adult enrollees in a Medicaid HMO. Psychiatr Serv 56 (2005) 1394-1401
23. Ray W.A., Gigante J., Mitchel Jr. E.F., and Hickson G.B. Perinatal outcomes following implementation of TennCare. JAMA 279 (1998) 314-316
24. US Department of Health and Human Services. A profile of Medicaid, Chartbook 2000. Electronic citation. Available at: http://www.cms.hhs.gov/TheChartSeries/downloads/2Tchartbk.pdf.
25. Hoyert D.L., Mathews T.J., Menacker F., Strobino D.M., and Guyer B. Annual summary of vital statistics: 2004. Pediatrics 117 (2006) 168-183
26. Food and Drug Administration. FDA public health advisory: treatment challenges of depression in pregnancy. Electronic citation. Available at: http://www.fda.gov/cder/drug/advisory/SSRI_PPHN200607.htm. Accessed July 19, 2006, August 7, 2006.
27. American College of Obstetricians and Gynecologists. Psychosocial risk factors: perinatal screening and intervention. Committee opinion no. 343. Obstet Gynecol 108 (2006) 469-477
28. Bonari L., Pinto N., Ahn E., Einarson A., Steiner M., and Koren G. Perinatal risks of untreated depression during pregnancy. Can J Psychiatry 49 (2004) 726-735